Your browser doesn't support javascript.
loading
Prediction Tools for Psychiatric Adverse Effects After Levetiracetam Prescription.
Josephson, Colin B; Engbers, Jordan D T; Jette, Nathalie; Patten, Scott B; Singh, Shaily; Sajobi, Tolulope T; Marshall, Deborah; Agha-Khani, Yahya; Federico, Paolo; Mackie, Aaron; Macrodimitris, Sophie; McLane, Brienne; Pillay, Neelan; Sharma, Ruby; Wiebe, Samuel.
Afiliação
  • Josephson CB; Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
  • Engbers JDT; Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Alberta, Canada.
  • Jette N; Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada.
  • Patten SB; O'Brien Institute for Public Health, University of Calgary, Calgary, Alberta, Canada.
  • Singh S; Desid Labs Inc, Calgary, Alberta, Canada.
  • Sajobi TT; Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
  • Marshall D; Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Alberta, Canada.
  • Agha-Khani Y; Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada.
  • Federico P; O'Brien Institute for Public Health, University of Calgary, Calgary, Alberta, Canada.
  • Mackie A; Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Macrodimitris S; Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Alberta, Canada.
  • McLane B; Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada.
  • Pillay N; O'Brien Institute for Public Health, University of Calgary, Calgary, Alberta, Canada.
  • Sharma R; Department of Psychiatry, University of Calgary, Calgary, Alberta, Canada.
  • Wiebe S; Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
JAMA Neurol ; 76(4): 440-446, 2019 04 01.
Article em En | MEDLINE | ID: mdl-30688969
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Prognóstico / Medição de Risco / Epilepsia / Levetiracetam / Transtornos Mentais / Anticonvulsivantes Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Neurol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Canadá País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Prognóstico / Medição de Risco / Epilepsia / Levetiracetam / Transtornos Mentais / Anticonvulsivantes Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Neurol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Canadá País de publicação: Estados Unidos